Literature DB >> 26778484

Organism burden, toxin concentration, and lactoferrin concentration do not distinguish between clinically significant and nonsignificant diarrhea in patients with Clostridium difficile.

Victoria Emma Anikst1, Rajiv Lochan Gaur1, Lee Frederick Schroeder2, Niaz Banaei3.   

Abstract

Clostridium difficile infection is often overdiagnosed in patients with mild diarrhea. We evaluated 4 biomarkers as surrogates for clinically significant diarrhea (≥ 3 episodes in 24 hours) in 59 PCR-positive patients with and 59 PCR-positive patients without clinically significant diarrhea. Organism burden (median tcdB cycle threshold value, 26.9 versus 27.1, P=0.25) and toxin A and B concentrations (toxin A, median, 0 versus 0 ng/mL, P=0.42; toxin B, median, 0 versus 0 ng/mL, P=0.25) were not significantly different between patients with and without clinically significant diarrhea. Fecal lactoferrin concentrations were significantly increased in patients with clinically significant diarrhea (median, 99.0 versus 55.1 μg/mL, P=0.05); however, lactoferrin could not sufficiently classify patients into those with and without clinically significant diarrhea. Interventions that limit C. difficile testing to patients with clinically significant diarrhea are needed to improve the positive predictive value of C. difficile diagnostics.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Biomarker; Clostridium difficile; Diarrhea; Infection; Lactoferrin; Toxin

Mesh:

Substances:

Year:  2015        PMID: 26778484     DOI: 10.1016/j.diagmicrobio.2015.11.022

Source DB:  PubMed          Journal:  Diagn Microbiol Infect Dis        ISSN: 0732-8893            Impact factor:   2.803


  11 in total

1.  Evaluation of the cobas Cdiff Test for Detection of Toxigenic Clostridium difficile in Stool Samples.

Authors:  Lance R Peterson; Stephen A Young; Thomas E Davis; Zi-Xuam Wang; John Duncan; Christopher Noutsios; Oliver Liesenfeld; John C Osiecki; Michael A Lewinski
Journal:  J Clin Microbiol       Date:  2017-09-27       Impact factor: 5.948

2.  Point-Counterpoint: What Is the Optimal Approach for Detection of Clostridium difficile Infection?

Authors:  Ferric C Fang; Christopher R Polage; Mark H Wilcox
Journal:  J Clin Microbiol       Date:  2017-01-11       Impact factor: 5.948

Review 3.  Laboratory Tests for the Diagnosis of Clostridium difficile.

Authors:  Karen C Carroll; Masako Mizusawa
Journal:  Clin Colon Rectal Surg       Date:  2020-02-25

4.  Nucleic Acid Amplification Test Quantitation as Predictor of Toxin Presence in Clostridium difficile Infection.

Authors:  M J T Crobach; N Duszenko; E M Terveer; C M Verduin; E J Kuijper
Journal:  J Clin Microbiol       Date:  2018-02-22       Impact factor: 5.948

5.  Real-Time Electronic Tracking of Diarrheal Episodes and Laxative Therapy Enables Verification of Clostridium difficile Clinical Testing Criteria and Reduction of Clostridium difficile Infection Rates.

Authors:  Cynthia Y Truong; Saurabh Gombar; Richard Wilson; Gopalakrishnan Sundararajan; Natasa Tekic; Marisa Holubar; John Shepard; Alexandra Madison; Lucy Tompkins; Neil Shah; Stan Deresinski; Lee F Schroeder; Niaz Banaei
Journal:  J Clin Microbiol       Date:  2017-03-01       Impact factor: 5.948

6.  Increased Clinical Specificity with Ultrasensitive Detection of Clostridioides difficile Toxins: Reduction of Overdiagnosis Compared to Nucleic Acid Amplification Tests.

Authors:  Johanna Sandlund; Joel Estis; Phoebe Katzenbach; Niamh Nolan; Kirstie Hinson; Jennifer Herres; Troy Pero; Gwyn Peterson; Jeung-Mi Schumaker; Craig Stevig; Rhonda Warren; Tsubasa West; Siu-Kei Chow
Journal:  J Clin Microbiol       Date:  2019-10-23       Impact factor: 5.948

7.  Toxin positivity and tcdB gene load in broad-spectrum Clostridium difficile infection.

Authors:  Hyeong Nyeon Kim; Hanah Kim; Hee-Won Moon; Mina Hur; Yeo-Min Yun
Journal:  Infection       Date:  2017-12-07       Impact factor: 3.553

Review 8.  Ultrasensitive Clostridioides difficile Toxin Testing for Higher Diagnostic Accuracy.

Authors:  Johanna Sandlund; Kerrie Davies; Mark H Wilcox
Journal:  J Clin Microbiol       Date:  2020-05-26       Impact factor: 5.948

Review 9.  Current knowledge on the laboratory diagnosis of Clostridium difficile infection.

Authors:  Adrián Martínez-Meléndez; Adrián Camacho-Ortiz; Rayo Morfin-Otero; Héctor Jesús Maldonado-Garza; Licet Villarreal-Treviño; Elvira Garza-González
Journal:  World J Gastroenterol       Date:  2017-03-07       Impact factor: 5.742

10.  Fecal host biomarkers predicting severity of Clostridioides difficile infection.

Authors:  Makan Golizeh; Kaitlin Winter; Lucie Roussel; Marija Landekic; Mélanie Langelier; Vivian G Loo; Momar Ndao; Donald C Vinh
Journal:  JCI Insight       Date:  2021-01-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.